Edgewise Therapeutics (EWTX) Financials: Revenue & Earnings

EWTX price $40.42 +0.90 +2.26%

Ticker
EWTX
Price
$40.42
Change
+0.90 +2.26%
Market cap ?
$4.35B
P/E ?
-21.25
Dividend yield ?
0.00%
Beta ?
0.28
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
54
Value
34
Quality
47
Growth
81

Stocklytics score rationale: value 34, quality 47, growth 81.

Financials

2019202020212022202320242025
0000000

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1…

Fair value

EWTX fair value Not meaningful. Price $40.42.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare EWTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.53—119.23M
2026-08-06-0.53-0.47——
2026-05-07-0.46-0.50——
2026-02-26-0.47-0.43——
2025-11-06-0.39-0.40——
2025-08-07-0.34-0.42——
2025-05-08-0.43-0.45——
2025-03-03-0.42-0.39——
2024-11-07-0.36-0.37——
2024-08-08-0.34-0.36——
2024-05-09-0.33-0.39——
2024-02-22-0.47-0.442.25M—
2023-11-09-0.41-0.40——
2023-08-10-0.34-0.41——
2023-05-11-0.36-0.37——
2023-02-23-0.31-0.36——
2022-11-03-0.34-0.36——
2022-08-04-0.32-0.34——
2022-05-11-0.30-0.29——
2022-02-24-0.26-0.28——
2021-11-10-0.26-0.22——
2021-08-09-0.21-0.18——
2021-05-13-4.37-0.16——
2021-03-26-0.18———
2020-12-31-0.31———
2020-06-30-0.19———
2020-03-31-0.16———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Fox Jonathan CBuy308——
2026-08-13Donovan Joanne M.Sell2.92K$43.41126.70K
2026-08-12Nofi MichaelBuy48.75K$43.562.12M
2026-08-12Donovan Joanne M.Buy65.00K$43.562.83M
2026-08-12Russell Alan JBuy65.00K$43.562.83M
2026-08-12MOORE JOHN RBuy65.00K$43.562.83M
2026-08-12Derakhshan BehradBuy100.00K$43.564.36M
2026-08-12Nofi MichaelBuy48.75K——
2026-08-12Nofi MichaelBuy24.38K——
2026-08-12Donovan Joanne M.Buy65.00K——
2026-08-12Donovan Joanne M.Buy32.50K——
2026-08-12Donovan Joanne M.Sell7.03K——
2026-08-12Donovan Joanne M.Buy7.03K——
2026-08-12Donovan Joanne M.Sell2.84K$43.78124.30K
2026-08-12Donovan Joanne M.Sell2.78K$43.71121.46K
2026-08-12Donovan Joanne M.Sell104$44.434.62K
2026-08-12Donovan Joanne M.Sell5.78K——
2026-08-12Donovan Joanne M.Sell800$44.5235.61K
2026-08-12Donovan Joanne M.Buy5.78K——
2026-08-12Russell Alan JBuy65.00K——
2026-08-12Russell Alan JBuy7.03K——
2026-08-12Russell Alan JSell3.24K$43.68141.43K
2026-08-12Russell Alan JBuy32.50K——
2026-08-12Russell Alan JSell2.27K$43.6899.28K
2026-08-12Russell Alan JSell390$44.4617.34K
2026-08-12Russell Alan JBuy5.78K——
2026-08-12Russell Alan JSell7.03K——
2026-08-12Russell Alan JSell5.78K——
2026-08-12MOORE JOHN RBuy65.00K——
2026-08-12MOORE JOHN RBuy32.50K——
2026-08-12MOORE JOHN RBuy6.72K——
2026-08-12MOORE JOHN RSell2.44K$43.81106.85K
2026-08-12MOORE JOHN RSell59$44.412.62K
2026-08-12MOORE JOHN RSell6.72K——
2026-08-12MOORE JOHN RSell99$44.504.41K
2026-08-12MOORE JOHN RSell2.42K$43.80105.95K
2026-08-12MOORE JOHN RBuy5.78K——
2026-08-12MOORE JOHN RSell5.78K——
2026-08-12Derakhshan BehradBuy100.00K——
2026-08-12Derakhshan BehradBuy50.00K——
2026-08-12Derakhshan BehradBuy7.50K——
2026-08-12Derakhshan BehradSell2.17K$43.7995.08K
2026-08-12Derakhshan BehradSell304$44.5013.53K
2026-08-12Derakhshan BehradSell150$44.446.67K
2026-08-12Derakhshan BehradSell2.48K$43.70108.15K
2026-08-12Derakhshan BehradBuy5.78K——
2026-08-12Derakhshan BehradSell7.50K——
2026-08-12Derakhshan BehradSell5.78K——
2026-08-12KOCH KEVINBuy200.00K$43.568.71M
2026-08-12KOCH KEVINBuy100.00K——
2026-08-12KOCH KEVINBuy21.88K——
2026-08-12KOCH KEVINSell21.88K——
2026-08-12KOCH KEVINSell8.78K$43.64383.25K
2026-08-12KOCH KEVINSell8.28K$43.66361.32K
2026-08-12KOCH KEVINSell913$44.3340.47K
2026-08-12KOCH KEVINBuy17.97K——
2026-08-12KOCH KEVINSell17.97K——
2026-07-01Russell Alan JSell69.65K$0.1812.54K
2026-07-01Russell Alan JBuy69.65K$0.1812.54K
2026-07-01Russell Alan JBuy130.35K$0.4558.66K
2026-07-01Russell Alan JSell130.35K$39.415.14M
2026-07-01Russell Alan JSell69.65K$39.412.74M
2026-07-01Russell Alan JSell130.35K$0.4558.66K
2026-07-01Fox Jonathan CBuy319——
2026-06-05ROOT JONATHAN DBuy16.38K$35.59582.86K
2026-06-05Brege LauraBuy16.38K$35.59582.86K
2026-06-05Thompson Peter A.Buy16.38K$35.59582.86K
2026-06-05Morris ArleneBuy16.38K$35.59582.86K
2026-06-05Edris BadreddinBuy8.19K$35.59291.41K
2026-06-05Edris BadreddinBuy5.62K——
2026-06-05Martin Christopher NathanBuy16.38K$35.59582.86K
2026-06-05Fox Jonathan CBuy16.38K$35.59582.86K
2026-05-05Donovan Joanne M.Sell50.00K$7.08354.00K
2026-05-05Donovan Joanne M.Buy50.00K$7.08354.00K
2026-05-05Donovan Joanne M.Sell50.00K$38.571.93M
2026-05-04Donovan Joanne M.Sell5.23K$31.29163.66K
2026-04-01Fox Jonathan CBuy339——
2026-04-01Donovan Joanne M.Sell28.66K$7.08202.93K
2026-04-01Donovan Joanne M.Buy28.66K$7.08202.93K
2026-04-01Donovan Joanne M.Sell28.66K$32.31926.10K
2026-03-31Donovan Joanne M.Sell21.34K$7.08151.07K
2026-03-31Donovan Joanne M.Buy21.34K$7.08151.07K
2026-03-31Donovan Joanne M.Sell21.34K$32.12685.31K
2026-03-27Donovan Joanne M.Sell9.62K$30.98298.10K
2026-03-27Donovan Joanne M.Sell6.74K$30.98208.64K
2026-01-21Edris BadreddinBuy7.61K$0.715.40K
2026-01-21Edris BadreddinBuy66.48K$1.93128.30K
2026-01-21Edris BadreddinSell13.69K$29.44403.03K
2026-01-21Edris BadreddinSell17.24K$29.44507.43K
2026-01-21Edris BadreddinSell7.61K$29.44223.89K
2026-01-21Edris BadreddinSell10.46K$29.44308.03K
2026-01-21Edris BadreddinBuy10.46K$1.9320.19K
2026-01-21Edris BadreddinBuy17.24K$0.6411.03K
2026-01-21Edris BadreddinBuy13.69K$0.395.34K
2026-01-21Edris BadreddinSell66.48K$29.441.96M
2026-01-21Edris BadreddinSell13.69K$0.395.34K
2026-01-21Edris BadreddinSell7.61K$0.715.40K
2026-01-21Edris BadreddinSell66.48K$1.93128.30K
2026-01-21Edris BadreddinSell17.24K$0.6411.03K
2026-01-02Fox Jonathan CBuy473——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 238, holders +13 vs prior quarter. Ownership 111.86%.

HolderSharesChangeChange %Value
ORBIMED ADVISORS LLC15.52M00.00%630.52M
PARADIGM BIOCAPITAL ADVISORS LP10.22M2.85M+38.70%415.05M
RA CAPITAL MANAGEMENT, L.P.8.39M-2.04M-19.52%341.00M
BLACKROCK, INC.6.61M133.34K+2.06%268.42M
JUPITER TOPCO LLC6.08M6.08MNew246.95M
FMR LLC5.49M4.47M+439.71%223.02M
NOVO HOLDINGS A/S5.35M00.00%217.37M
DRIEHAUS CAPITAL MANAGEMENT LLC4.73M250.68K+5.60%192.12M
PERCEPTIVE ADVISORS LLC4.37M-50.00K-1.13%177.71M
VANGUARD CAPITAL MANAGEMENT LLC3.86M72.51K+1.91%156.86M
BAKER BROS. ADVISORS LP3.70M-2.87M-43.71%150.40M
SIREN, L.L.C.3.18M-1.25M-28.12%129.39M
CORMORANT ASSET MANAGEMENT, LP2.51M-750.00K-23.01%101.98M
GEODE CAPITAL MANAGEMENT, LLC2.17M384.23K+21.47%88.35M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC2.00M400.00K+25.00%81.26M
BRAIDWELL LP2.00M-350.62K-14.94%81.14M
MORGAN STANLEY1.95M-297.43K-13.24%79.17M
STATE STREET CORP1.83M111.10K+6.47%74.27M
ALLIANCEBERNSTEIN L.P.2.12M396.86K+23.04%66.75M
MPM BIOIMPACT LLC1.62M-39.92K-2.40%65.85M
BANK OF AMERICA CORP /DE/1.56M230.90K+17.40%63.31M
QUBE RESEARCH & TECHNOLOGIES LTD1.25M426.60K+51.65%50.89M
DIMENSIONAL FUND ADVISORS LP1.14M-79.99K-6.56%46.31M
AMERICAN CENTURY COMPANIES INC1.13M-20.10K-1.75%45.79M
FIRST LIGHT ASSET MANAGEMENT, LLC1.10M93.33K+9.32%44.50M

Earnings and financials

Edgewise Therapeutics, Inc. (EWTX) trades at $40.42, with a market cap of $4.35B and a trailing P/E of -21.25. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
0000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Edgewise Therapeutics (EWTX) Financials: Revenue & Earnings

EWTX$40.42+0.90 +2.26%

$4.35B

Market Cap

-21.25

P/E

—

Forward P/E

54

Score

Price History